top of page
Modern Architecture
Search

How $28.8B in Digital Health Investment Is Rewriting Insurance Rules


What if every dollar flowing into digital health right now is redrawing the map of how insurance will work tomorrow?


Key Takeaways:


  • Global digital health funding hit $28.8B in 2025, with mega-deals accounting for 49% of all investment

  • AI-enabled companies captured 54% of total funding, commanding a 19% premium on average deal size

  • Revenue cycle automation emerged as the top investment priority, with 75% of U.S. health systems planning AI-driven RCM expansion by 2026

  • OpenEvidence doubled its valuation to $12B in three months

  • Tebra raised $250M for AI-powered practice management

  • Insurance carriers must act now to partner with funded startups before competitors secure exclusive relationships


The numbers tell an unmistakable story. Global digital health funding reached $28.8 billion in 2025, marking a decisive shift from experimentation to enterprise-scale deployment. But here's what matters more: capital didn't return evenly after the post2021 correction. It concentrated into operational winners with demonstrable adoption, credible unit economics, and proven implementation capability.


For insurance carriers, agents, and digital marketers, this concentration reveals where the industry is actually heading versus where it claims to be going. And the gap between those two realities creates both risk and opportunity.


Market Reset: Fewer Bets, Bigger Checks, Higher Standards

The 2025 funding landscape marked a fundamental transformation. While total funding increased 9% year-over-year, deal count plummeted 33%. Translation: investors are placing larger bets on fewer companies, and those companies must prove that they can execute at scale.


Mega-deals of $100 million or more accounted for 49% of all digital health funding, with 65 mega-deals totaling $14 billion. This represents a market that has moved from promising potential to demanding performance.


The average deal size jumped to $29.3 million, up from $20.7 million in 2024. Beneath these averages lies a more complex reality: artificial intelligence (AI)-enabled companies commanded a 19% premium on deal size overall, and, at Series C, that premium jumped to 61%.


OpenEvidence's Moonshot: $250M at $12B Valuation

In a remarkable show of investor confidence, OpenEvidence just closed a $250 million Series D round at a $12 billion valuation. That's double what investors valued the company at during its $200 million round only three months earlier in October.


The company has raised almost $700 million to date. Thrive Capital and DST Global co-led this latest round.


Why does this meteoric rise matter to insurance? OpenEvidence built an AI-enabled search tool that helps clinicians to research information based on medical journals. The company has partnership deals with the American Medical Association (AMA)'s journals and the publisher of the New England Journal of Medicine.


When physicians make faster, evidence-based decisions using these tools, the downstream effects ripple through the entire insurance value chain. Claims become more defensible. Treatment plans improve. Costly complications and unnecessary procedures decrease. And prior authorization decisions gain stronger clinical grounding.


For insurance carriers, this represents an opportunity to integrate evidence-based medicine directly into utilization management workflows. The question is how quickly you can build those relationships before your competitors do.


AI in Revenue Cycle: From Pilot to Production

The market is putting real money into automating the revenue cycle. According to recent research, over 75% of U.S. health systems plan to expand AI-driven revenue cycle management (RCM) automation by 2026, with autonomous workflows across coding, billing, and denials ranking as top priorities.


All-in-one EHR platform Tebra raised $250 million in December to accelerate AI development across clinical documentation, billing automation, and practice marketing. The round was led by Hildred, with participation from J.P. Morgan and existing investors.


Tebra serves over 140,000 providers and manages 125 million patient records. Its AI Note Assist generated more than 500,000 clinical notes in the second half of 2025 alone, saving customers an average of 60% of documentation time per note.


The revenue cycle automation business case is straightforward: U.S. health care organizations lose over $262 billion annually due to revenue cycle inefficiencies including denials, undercoding, delayed follow-ups, and manual workflows. AI platforms promise to automate coding, billing, denials, and follow-ups with measurable return on investment (ROI).


For insurance carriers, this means fewer billing errors, faster claims processing, and reduced administrative overhead. But it also means that providers are getting sophisticated tools to challenge denials and maximize reimbursement. In order to remain competitive, your claims operations need equivalent technological capabilities.


Pediatric Care Opportunity: Zarminali's $110M Round

Zarminali Pediatrics raised $110 million in Series A funding for multispecialty care coordination for children. Healthier Capital, the new venture capital (VC) firm founded by Amir Dan Rubin, former One Medical CEO, contributed to the round.


Traditional insurance models struggle with pediatric specialty care coordination. Multiple providers, fragmented communication, and difficulty tracking treatment across specialists create both quality issues and cost inefficiencies.


Zarminali's model addresses these pain points by coordinating care across specialties. For insurance carriers, this represents an opportunity to reduce emergency department utilization, improve member satisfaction scores, and create value-based contract structures that align incentives.


When a pediatric practice uses an integrated care coordination platform, insurance products need to support that workflow. Your network design, referral management systems, and care coordination tools must interface seamlessly with these new models.


Virtual Behavioral Health: AnswersNow's $40M Validation

AnswersNow secured $40 million in Series B funding for its virtual applied behavioral analysis platform. HealthQuest Capital led the round, with participation from Left Lane Capital and Owl Ventures.


The company connects patients and families needing autism support services with board-certified behavioral analysts through digital channels. This addresses two problems simultaneously: access to specialized behavioral health services and the cost structure that makes those services prohibitive.


Virtual behavioral health platforms reduce overhead costs while expanding provider networks. For carriers, this creates opportunities to improve behavioral health access metrics, reduce crisis interventions, and support members with complex needs at sustainable costs.


The $40 million investment signals that growth equity sees sustainable unit economics in virtual specialty care. This has become a proven business model that insurance products need to accommodate.


Revenue Operations: Claim Health's $4.4M Seed

Claim Health raised $4.4 million in seed funding from Maverick Ventures, Peak XV, and Y Combinator. Their platform helps postacute care providers to manage payment reconciliation, intake, and eligibility verification through automation.


Postacute care represents one of the highest-cost, most administratively complex segments in health care. The administrative burden of managing multiple payers, varying coverage rules, and complex billing requirements costs billions annually.


For insurance agents, understanding these automation tools becomes a competitive advantage. You're not just offering coverage. You're offering access to systems that make managing that coverage dramatically easier for postacute providers.


When you can explain how your network includes providers using modern revenue operations platforms, you're speaking to real pain points that are stressful for administrators.


Venture Capital Intelligence: What Smart Money Sees

Healthier Capital closed its first fund with $220 million in commitments. Its portfolio reveals strategic investment themes worth studying closely.


It backed Qualified Health, which helps health systems implement AI tools. It invested in Ezra's advanced MRI scanning technology, which was later acquired by Function Health. Most recently, it contributed to Zarminali's $110 million round.


This makes it clear that investors are betting on companies that make specialized care more accessible and affordable through better coordination and technology infrastructure.


For insurance carriers, these investment patterns reveal market direction months before it becomes obvious in claims data or member behavior. Following VC investment flows provides early warning of which health care delivery models will scale and which will remain niche experiments.


Market Bifurcation: Tale of Two Markets

The most consequential trend in 2025 wasn't any single funding round. It was the bifurcation of the digital health market into distinct tiers.


Companies demonstrating operating profitability, earnings before interest, taxes, depreciation, and amortization (EBITDA) visibility as well as enterprise adoption and defensible data assets raised enormous rounds. Those without these characteristics struggled to raise capital at any valuation.


Five companies broke the three-year public exit drought in 2025: Hinge Health, Omada Health, Heartflow, Carlsmed, and Profusa. Their initial public offerings (IPOs) matter because they return capital to investors, unfreeze the investment cycle, and create validated comparisons for future fundraises and exits.


Private equity health care technology spend saw a reported 600% increase as firms placed major bets on established winners. This influx of growth capital creates acquisition opportunities, partnership possibilities, and competitive threats depending on your market position.


What This Means for Insurance Strategy in 2026

The funding patterns reveal three critical implications for insurance executives.


First, AI adoption has moved from optional to essential. Health systems are deploying AI not for innovation theater but for operational necessity. Financial pressures from declining reimbursements, workforce shortages, and rising costs make efficiency gains nonnegotiable.


Second, the technology stack is consolidating. Providers are reducing vendor relationships and seeking integrated platforms that handle multiple functions. Your claims systems, provider portals, and member tools must integrate seamlessly with these consolidated platforms or risk becoming friction points that drive providers out of network.


Third, health care delivery models are fragmenting and specializing. Virtual-first behavioral health, coordinated pediatric care, evidence-based clinical research tools, and AI-powered revenue cycle platforms aren't replacing traditional care. They're creating parallel infrastructure that serves specific populations and use cases better than traditional models.


Taking Action: From Insight to Implementation

Start by mapping funded companies against your strategic priorities. Which of these platforms address gaps in your network? Where do provider pain points align with funded solutions?


OpenEvidence's partnerships with major medical publishers didn't happen overnight. Tebra's $250 million round reflects years of product development and market validation. By the time these solutions are ubiquitous, the best partnership terms will have been taken.


Identify pilot opportunities now. Claim Health's automation for postacute care, AnswersNow's virtual behavioral health platform, or Zarminali's pediatric coordination model may solve specific network or quality challenges that you're facing.


For digital marketers, understand that provider and member experiences are being transformed by these platforms. Marketing messages need to speak to integrated care experiences, AI-assisted decision making, and seamless digital workflows. Generic "quality care" messaging won't resonate with audiences that are already using sophisticated digital tools daily.


Insurance agents gain credibility by understanding the technology landscape that their clients navigate. Knowing which revenue cycle platforms reduce administrative burden, which virtual care options expand access, and which coordination tools improve outcomes becomes part of your value proposition.


Sources: 



Further Thoughts

Notice what's getting funded in 2025 and early 2026: revenue cycle automation, clinical decision support, care coordination platforms, and practice management systems. In other words, health care infrastructure.


This represents a maturation of digital health investing. Capital flows to companies solving operational problems with measurable ROI rather than chasing consumer engagement metrics or wellness trends.


For insurance, this shift creates partnership opportunities with companies that have clear paths to profitability and sustainable business models. You're not betting on unproven consumer behavior changes. You're investing in tools that make existing workflows more efficient and outcomes more measurable.


The companies raising capital today are building the systems you'll be integrating tomorrow. The digital transformation of health care is here, funded to the tune of $28.8 billion globally in 2025, and accelerating into 2026.


These funding rounds represent market signals about where health care delivery is heading, which business models will scale, and what infrastructure will define the next decade of care delivery.


The only question is whether you'll be shaping that transformation or responding to it.


Follow us on LinkedIn and join the Insurance Marketing Coalition (IMC) to connect with fellow members.


Recent Posts

See All
Voice of the Coalition: Death of an AOR

AOR displacement is not a small administrative issue. It can disrupt member care, create confusion, and weaken trust across the Medicare ecosystem. Join us on Wednesday, March 25 at 11:00 AM ET for Vo

 
 
 

Comments

The IMC Blog

bottom of page